Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase II trial of streptozocin in the treatment of advanced renal cell carcinoma.

Licht JD, Garnick MB. Phase II trial of streptozocin in the treatment of advanced renal cell carcinoma. Cancer Treat Rep. 1987 Jan; 71(1):97-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.